We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 13, 2022

An mRNA-Based Urine Test for Surveillance in Patients With NMIBC

BJU International


Additional Info

Disclosure statements are available on the authors' profiles:

BJU International
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer
BJU Int 2021 Dec 01;128(6)713-721, B Cowan, E Klein, K Jansz, K Westenfelder, T Bradford, C Peterson, D Scherr, LI Karsh, B Egerdie, A Witjes, A Trainer, R Harris, B Goldfarb, S Flax, R Kroeger, B Boyd, J Liao, S Patel, J Bridge, V Reuter, N Quigley, S Brown, S Zhao, M Satya, M Bates, IM Simon, S Campbell, Y Lotan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading